Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss APLS - Apellis Pharmaceuticals, Inc.
-3.54 M
LAST VALUE
-30.18%
2 YEAR CAGR
-95.89%
5 YEAR CAGR
-72.02%
10 YEAR CAGR